Global hormone replacement therapy market is expected to grow at a lucrative rate throughout the forecast period owing to rise in woman population base that is undergoing through menopause coupled with increasing patient awareness towards menopausal hazards. Favorable government initiatives which include increasing government and corporate funding pertaining to the R&D of bioidentical drugs are expected to further promote the market demand during the forecast period. Furthermore, increasing market penetration as a consequence of higher efficacy of approved bioidentical therapies, advantages offered by estrogen and progesterone for treatment of chronic ailments, and increasing research studies in the field of hormone replacement therapy are also expected to fuel hormone replacement therapy market growth in the next seven years.
Browse full research report on Global Hormone Replacement Therapy Market: http://www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market

Increasing uses of hormone replacement therapy in the treatment of anti ageing and vaginal estrogen therapy due to comparatively safe profile, efficiency, and cost effectiveness of these drugs is expected to positively reinforce market growth. Moreover, new formulations such as transdermal drugs, gels and creams that offer benefits such as increased bioavailability and ease of drug delivery are expected to boost the growth of hormone replacement therapy market during the forecast period. Furthermore, advantages associated with the hormone replacement therapy such as reduction in risk of occurrence of osteoporosis, cardiovascular disease, and reduction of vasomotor symptoms are also anticipated to impact hormone replacement therapy market growth positively in the coming years.
Request For TOC of this report: http://www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market/request-toc
On the basis of geography the market is segmented into North America, Europe, Asia Pacific Latin America and MEA. In 2014, North America was the highest revenue generating regional market owing to increasing number of research studies investigating hormone replacement coupled with rise in novel product development such as needle free injections and devices which can serve pediatric population dealing with human growth hormone deficiencies. The other factors attributing to its large share include high per capita income coupled with high disposable income of the population base. Asia Pacific hormone replacement therapy market is expected to witness lucrative growth over the next seven years. Key factors attributing to its rapid growth include constant development of health care infrastructure in emerging economies such India and China.
Access More reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Furthermore, increasing corporate and government funding in the biotechnology and biopharmaceutical industry, rise in number of research institutes and diagnostic laboratories in the region, and presence of unmet market demand is expected to boost hormone replacement therapy market in the region. The hormone replacement therapy market is highly competitive owing to emergence of new entrants in the market and the presence of well established firms. The major participants in hormone replacement therapy include Pfizer, Mylan Corporation, Amgen, QuatRx Pharmaceuticals, Merck & co., Noven Pharmaceuticals, BioSante Pharmaceuticals and Depomed Inc.

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

For more information, visit: http://www.grandviewresearch.com/

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Read our blogs - www.divog.org, www.terrapass.org, www.apavirginia.org